Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siegfried Janz

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
Molecular Cancer|June 6, 2021
CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myelomaChunyan Gu, Wang Wang, Xiaozhu Tang, et al.
HLA|February 13, 2026
Fine Mapping of MHC Region Identifies Novel Susceptibility Loci in Multiple Myeloma When Comparing With Its Precursor Monoclonal Gammopathy of Unknown SignificanceShahram Arsang-Jang, Ben Massat, Gokul Pareek, et al.
Cancer Research|March 17, 2007
Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cellsChen-Feng Qi, Jeff X Zhou, Chang Hoon Lee, et al.
Plos One|November 14, 2014
NIAM-deficient mice are predisposed to the development of proliferative lesions including B-cell lymphomasSara M Reed, Jussara Hagen, Viviane P Muniz, et al.
Plos One|October 17, 2013
Identification of candidate B-lymphoma genes by cross-species gene expression profilingVan S Tompkins, Seong-Su Han, Alicia Olivier, et al.
Blood Advances|February 1, 2023
A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancyAriel Kleman, Arun Singavi, Lauren Pommert, et al.
Blood Cancer Journal|March 5, 2024
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencingJian-Rong Li, Shahram Arsang-Jang, Yan Cheng, et al.
Optics Letters|October 15, 2020
Highly efficient optical antenna with small beam divergence in silicon waveguidesPablo Ginel-Moreno, Daniel Pereira-Martín, Abdelfettah Hadij-ElHouati, et al.
British Journal of Haematology|December 6, 2023
Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantationLindsay Hammons, Shabi Haider, Andrew J Portuguese, et al.
Molecular Cancer Therapeutics|March 29, 2013
Profiling bortezomib resistance identifies secondary therapies in a mouse myeloma modelHolly A F Stessman, Linda B Baughn, Aaron Sarver, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
Molecular Cancer|June 6, 2021
CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myelomaChunyan Gu, Wang Wang, Xiaozhu Tang, et al.
HLA|February 13, 2026
Fine Mapping of MHC Region Identifies Novel Susceptibility Loci in Multiple Myeloma When Comparing With Its Precursor Monoclonal Gammopathy of Unknown SignificanceShahram Arsang-Jang, Ben Massat, Gokul Pareek, et al.
Cancer Research|March 17, 2007
Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cellsChen-Feng Qi, Jeff X Zhou, Chang Hoon Lee, et al.
Plos One|November 14, 2014
NIAM-deficient mice are predisposed to the development of proliferative lesions including B-cell lymphomasSara M Reed, Jussara Hagen, Viviane P Muniz, et al.
Plos One|October 17, 2013
Identification of candidate B-lymphoma genes by cross-species gene expression profilingVan S Tompkins, Seong-Su Han, Alicia Olivier, et al.
Blood Advances|February 1, 2023
A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancyAriel Kleman, Arun Singavi, Lauren Pommert, et al.
Blood Cancer Journal|March 5, 2024
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencingJian-Rong Li, Shahram Arsang-Jang, Yan Cheng, et al.
Optics Letters|October 15, 2020
Highly efficient optical antenna with small beam divergence in silicon waveguidesPablo Ginel-Moreno, Daniel Pereira-Martín, Abdelfettah Hadij-ElHouati, et al.
British Journal of Haematology|December 6, 2023
Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantationLindsay Hammons, Shabi Haider, Andrew J Portuguese, et al.
Molecular Cancer Therapeutics|March 29, 2013
Profiling bortezomib resistance identifies secondary therapies in a mouse myeloma modelHolly A F Stessman, Linda B Baughn, Aaron Sarver, et al.
Pageof 16